Global Medicines Export Policy
Drug Policy
Clear guidance on generic medicines, affordability, patent expiry, and GME quality expectations.What Are Generic Medicines?
Generic medicines contain the same active ingredient, strength, dosage form, and intended therapeutic effect as their branded equivalents. They are generally introduced after the original product patent or market exclusivity period expires.
Quality and Bioequivalence
Generic medicines are expected to meet applicable quality, safety, effectiveness, and bioequivalence standards. Bioequivalence means the medicine performs in the body in a comparable way to the reference product.
Reduced Development Cost
Generic manufacturers do not repeat the full drug discovery and clinical development process because the original medicine has already established the active ingredient, safety profile, and intended therapeutic use.
Lower Marketing Expense
Generic medicines normally carry lower branding and promotional costs than originator brands. This can help make treatment options more affordable for customers and healthcare systems.
Established Manufacturing
Generics are produced using established formulations and manufacturing processes while still requiring product quality, consistency, and suitable regulatory compliance.
Competition and Access
After patent expiry, more than one manufacturer may produce the same medicine. Competition can reduce prices and improve wider access to important therapies.
Patent Protection
New medicines are commonly protected by patents for a limited time. After expiry, qualified manufacturers may produce generic versions that meet required standards.
Our Commitment
Global Medicines Export aims to support affordable healthcare access by sourcing quality pharmaceutical products from reputable manufacturers and presenting product information responsibly.